BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7700366)

  • 1. International fund fosters cross-border Irish research.
    Abbott A
    Nature; 1995 Apr; 374(6522):488. PubMed ID: 7700366
    [No Abstract]   [Full Text] [Related]  

  • 2. On the road to California.
    DeWitt N
    Nature; 2002 Dec; 420(6916 Suppl):A9. PubMed ID: 12510695
    [No Abstract]   [Full Text] [Related]  

  • 3. Changing university roles in the century of biotechnology.
    Meagher LR; Bolivar F
    Nat Biotechnol; 1998 Jul; 16(7):598-9. PubMed ID: 9661170
    [No Abstract]   [Full Text] [Related]  

  • 4. Syngenta ends plant-research deal with Berkeley.
    Dalton R
    Nature; 2003 Nov; 426(6964):216. PubMed ID: 14628007
    [No Abstract]   [Full Text] [Related]  

  • 5. New Zealand launches biotech seed fund.
    Griggs K
    Nat Biotechnol; 2004 Apr; 22(4):480-1. PubMed ID: 15085809
    [No Abstract]   [Full Text] [Related]  

  • 6. Building Nordic networks.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A3, A5, A7. PubMed ID: 12501120
    [No Abstract]   [Full Text] [Related]  

  • 7. Berkeley dispute festers over biotech deal.
    Dalton R
    Nature; 1999 May; 399(6731):5. PubMed ID: 10331373
    [No Abstract]   [Full Text] [Related]  

  • 8. Blurred vision.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
    [No Abstract]   [Full Text] [Related]  

  • 9. Irish researchers divided over how to spend huge new fund.
    Abbott A
    Nature; 2000 Mar; 404(6775):215. PubMed ID: 10749176
    [No Abstract]   [Full Text] [Related]  

  • 10. Portugal opens its borders to biotechnology.
    Louët S
    Nat Biotechnol; 2000 Mar; 18(3):276-7. PubMed ID: 10700139
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing an intellectual property portfolio for the academic or not-for-profit institution.
    Bloomberg CA
    Nat Biotechnol; 2005 Jan; 23(1):119-21. PubMed ID: 15637626
    [No Abstract]   [Full Text] [Related]  

  • 12. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
    [No Abstract]   [Full Text] [Related]  

  • 13. Ireland's new biotechnology venture puts marketing first.
    Wenz C
    Nature; 1988 Feb; 331(6157):553. PubMed ID: 3340205
    [No Abstract]   [Full Text] [Related]  

  • 14. Japan finds a key to unlock philanthropy.
    Cyranoski D
    Nature; 2012 Feb; 482(7384):143. PubMed ID: 22318582
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ireland embraces biotechnology.
    Canning S
    Nat Biotechnol; 2000 Mar; 18(3):273-5. PubMed ID: 10700138
    [No Abstract]   [Full Text] [Related]  

  • 17. International biotech centre opens in Delhi with plea for cash.
    Jayaraman KS
    Nature; 1996 Mar; 380(6569):4. PubMed ID: 8598901
    [No Abstract]   [Full Text] [Related]  

  • 18. An embargoed Cuban science.
    Smith C
    Genet Anal; 1999 Nov; 15(3-5):71-2. PubMed ID: 10596742
    [No Abstract]   [Full Text] [Related]  

  • 19. The National University of Singapore and what it does.
    Halliwell B
    Biointerphases; 2010 Sep; 5(3):FA15-8. PubMed ID: 21171707
    [No Abstract]   [Full Text] [Related]  

  • 20. Building cooperation New York.
    Smaglik P
    Nature; 2002 Sep; 419(6905):4-5. PubMed ID: 12352990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.